Last reviewed: June 26, 2026

Last updated: June 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, originally developed as a type 2 diabetes medication, has demonstrated remarkable effectiveness for weight loss in multiple clinical trials. The medication works by mimicking glucagon-like peptide-1 (GLP-1), a hormone that controls hunger and blood sugar levels. PlexusDx provides compounded semaglutide injections starting at $149 per month, giving patients access to this evidence-based therapy without the barriers of brand-name pricing.

How Semaglutide Works for Weight Loss

Semaglutide is a GLP-1 receptor agonist, meaning it activates specific receptors in your brain that regulate appetite and satiety. When these receptors are activated, your brain receives signals that you feel full sooner and remain satisfied longer between meals. This mechanism naturally reduces calorie intake without requiring restrictive dieting or intense willpower.

Clinical studies show that patients using semaglutide experience reduced cravings for high-calorie foods and decreased overall food intake. The medication also slows gastric emptying, which means food stays in your stomach longer, extending feelings of fullness. Additionally, semaglutide may improve how your body processes glucose, supporting metabolic health beyond simple weight reduction.

Clinical Evidence for Semaglutide Weight Loss Results

The landmark STEP trials demonstrated that patients taking semaglutide lost between 15% and 22% of their body weight over 68 weeks, depending on dose level. These results are substantially higher than those achieved with lifestyle changes alone or previous weight loss medications. Real-world patient data consistently supports these findings across diverse age groups and metabolic backgrounds.

Weight loss typically begins within 2-4 weeks of starting treatment, though individual timelines vary based on genetics, metabolism, and adherence. Patients report improved energy levels, better blood pressure readings, and reduced joint stress as weight decreases. The medication has also shown benefits for cardiovascular health markers, independent of weight loss itself.

Semaglutide vs. Ozempic: Understanding Your Options

Ozempic is the branded version of semaglutide manufactured by Novo Nordisk, but it carries a significantly higher price tag due to brand markup and distribution costs. PlexusDx offers compounded semaglutide from licensed 503A pharmacies, which provides the same active ingredient at a fraction of the cost. Both require a prescription and work identically in your body, though compounded versions allow greater pricing accessibility.

The key difference is access and affordability. Brand-name Ozempic can cost $800-$1,200 monthly without insurance, while PlexusDx compounded semaglutide starts at $149 per month. PlexusDx serves all 50 states, accepts HSA and FSA payments, and requires no insurance or membership fees. Your dose may need to go up as your body adapts, but your price won't increase with PlexusDx's flat monthly commitment tiers.

Is Semaglutide the Right Choice for Your Weight Loss Journey?

Semaglutide works best for patients with a BMI of 30 or higher, or those with a BMI of 27+ who have weight-related health conditions like high blood pressure or type 2 diabetes. It's most effective when combined with sustainable lifestyle changes including balanced nutrition and regular movement. However, individual genetics play a significant role in how your body responds to GLP-1 therapy.

PlexusDx offers the Precision Peptide Genetic Test, which analyzes key variants like GLP1R rs6923761 and GIPR rs1800437 to predict your individual response to semaglutide and other peptide therapies. This $99 add-on test maps 14 pathways and 49 peptides to personalize your treatment plan. Understanding your genetic predispositions helps your healthcare provider determine if semaglutide is optimal for you, or if alternative compounds like tirzepatide might deliver better results.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results with semaglutide?

Most patients notice appetite suppression within 2-4 weeks and measurable weight loss within 4-8 weeks of starting treatment. Results continue improving over 3-6 months as your dose stabilizes. Individual timelines depend on starting weight, metabolism, and lifestyle factors alongside medication use.

What clinical evidence supports semaglutide for weight loss?

The STEP clinical trials published in major medical journals demonstrated that patients lost 15-22% of their body weight over 68 weeks with semaglutide. These results far exceed outcomes from diet and exercise alone or previous weight loss medications. Real-world outcomes consistently match or exceed trial results across diverse patient populations.

How much does PlexusDx compounded semaglutide cost compared to Ozempic?

PlexusDx compounded semaglutide starts at $149 per month with flat pricing across three commitment tiers, while brand-name Ozempic typically costs $800-$1,200 monthly. PlexusDx requires no insurance, membership fee, or separate payments—your dose may increase, but your price won't. HSA and FSA funds are accepted for all medications.

Are there side effects with semaglutide I should know about?

Common mild side effects include nausea, constipation, or reduced appetite—though appetite reduction is the intended therapeutic effect. These typically resolve within 2-4 weeks as your body adjusts. Serious side effects are rare but may include pancreatitis; patients with personal or family history of medullary thyroid cancer should not use GLP-1 medications.

Can the Precision Peptide Genetic Test predict how I'll respond to semaglutide?

Yes. PlexusDx's $99 Precision Peptide Genetic Test analyzes GLP1R rs6923761, GIPR rs1800437, and 47 other peptide-pathway variants to predict your individual response to semaglutide and alternative compounds. This genetic insight helps your provider optimize your treatment before you start, potentially faster results and better long-term outcomes.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves